Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits

NCT04758299 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2021-05-25

No results posted yet for this study

Summary

To test competing sets of information for consumers on how to interpret hypothetical SARS-CoV-2 home test kit results and whether they report plans to take CDC-recommended actions to protect themselves and others given their test results and two critical aspects of their clinical context: symptoms, recent close exposures. Participants will be randomized to receive either information from the FDA authorized Ellume home test kit (the first kit authorized for over the counter use) for what actions to take for a negative or positive COVID-19 test (usual care) or a decision science-based design of similar length (intervention).

Conditions

  • COVID-19 Testing
  • Decision Making

Interventions

OTHER

decision science-based design

decision science-based design explaining actions to take for a negative or positive COVID-19 test

Sponsors & Collaborators

  • Dartmouth College

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • Barry Dewitt

    lead OTHER

Principal Investigators

  • Barry Dewitt · Carnegie Mellon University

  • Steven Woloshin, MD · Dartmouth College

  • Tamar Krishnamurti, PhD · University of Pittsburgh

  • Baruch Fischhoff, PhD · Carnegie Mellon University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-13
Primary Completion
2021-04-15
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04758299 on ClinicalTrials.gov